Venezuela lawmakers elect Chavez ally as Assembly chief

Venezuela lawmakers elect Chavez ally as Assembly chief

CARACAS (Reuters) - Venezuelan lawmakers re-elected a staunch ally of Hugo Chavez to head the National Assembly on Saturday, putting him in line to be caretaker president if the socialist leader does not recover from cancer surgery. By choosing the incumbent, Diosdado Cabello, the "Chavista"-dominated legislature cemented the combative ex-soldier's position as the third most powerful figure in the government, after Chavez and Vice President Nicolas Maduro. "As a patriot ... ...

Source: news.yahoo.com

Indian court to rule on generic drug industry

NEW DELHI (AP) — From Africa's crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging in the balance ahead of a legal ruling that will determine whether India's drug companies can continue to provide cheap versions of many life-saving medicines.

Click here to read the rest

Analysis: Alimta patent seen as Lilly's "wild card"

NEW YORK (Reuters) - Eli Lilly & Co may have a $15 billion wild card up its sleeve as it waits for desperately needed new drugs to bear fruit. Should an obscure patent on Lilly lung cancer drug Alimta survive a court challenge this year, the company would be able to wring more than five additional years of peak sales out of the fast-growing product that it would otherwise lose to cheaper generics. Annual sales of Alimta are expected by Wall Street to climb to $3.5 billion by 2016, when its basic patent lapses. ... Read more

Analysis: Alimta patent seen as Lilly's "wild card"

Analysis: Alimta patent seen as Lilly's "wild card"
NEW YORK (Reuters) - Eli Lilly & Co may have a $15 billion wild card up its sleeve as it waits for desperately needed new drugs to bear fruit. Should an obscure patent on Lilly lung cancer drug Alimta survive a court challenge this year, the company would be able to wring more than five additional years of peak sales out of the fast-growing product that it would otherwise lose to cheaper generics. Annual sales of Alimta are expected by Wall Street to climb to $3.5 billion by 2016, when its basic patent lapses. ...
Source: news.yahoo.com

Get Fit for 2013: Trainer Harley Pasternak Answers 'GMA' Viewers' Questions

Get Fit for 2013: Trainer Harley Pasternak Answers 'GMA' Viewers' Questions
It’s a new year and many people have made resolutions to get fit. Celebrity trainer Harley Pasternak (@harleypasternak) has trained celebrities including Rihanna and Katy Perry and this morning he appeared on “Good Morning America” to show specific exercise moves to get you an all-star...
Source: news.yahoo.com